Fundraising Fox

Phoundry Pharmaceuticals

Research Triangle Park, US · Founded 2015 · Delaware corporation

Biotech

Founders & leadership

PL
Paul L FeldmanNamed on SEC filing
AY
Andrew YoungNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 1 round · 2015

▶$500KraisedAug 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul L FeldmanExecutive Officer, Director, Promoter
  • Shane RollerPromoter
  • Ved SrivastavaPromoter
  • Andrew YoungExecutive Officer, Director, Promoter
  • Mark PaulikPromoter
  • James WayPromoter
Offering amount
$1M
Amount sold
$500K
Minimum investment
$50K
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Phoundry - Hemera Financial Solutionshemerafs.com · Oct 2015Six GlaxoSmithKline Researchers Found Phoundry Pharma | BioSpacebiospace.com · Aug 2015New Peptide Company Phoundry Closes First Seed Funding | Fierce Biotechfiercebiotech.com · Aug 2015A GSK layoff helps launch new RTP drug developer Phoundry Pharmaceuticals, Inc. - Triangle Business Journalbizjournals.com · Aug 2015

Frequently asked questions

How much funding has Phoundry Pharmaceuticals raised?
Phoundry Pharmaceuticals has disclosed $500K raised across 1 round.
Where is Phoundry Pharmaceuticals headquartered?
Phoundry Pharmaceuticals is headquartered in Research Triangle Park, US.